Metabolism of nabumetone (BRL 14777) by various species including man.
Radiotracer methodology was used to study the metabolic fate of 4-(6-methoxy-2-naphthyl)-butan-2-one (nabumetone) after oral administration to rats, mice, rabbits, dogs, rhesus monkeys and healthy human subjects. Parent compound was not detected in plasma and urine and the major circulating metabolite in all species was identified as 6-methoxy-2-naphthylacetic acid, a compound known to possess anti-inflammatory activity. Metabolites were mainly excreted in urine from which four principal metabolites were isolated and identified by mass spectrometry and independent synthesis. Pathways involving O-demethylation, reduction of the ketone group and oxidation of the butanone side-chain to acetic acid occurred in all species, but the ratios of the metabolic end-products tended to be species dependent. In the rat about half of the administered nabumetone was oxidized to the pharmacologically active acid metabolite.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000378:metabolism*; D002074:Butanones / Q000378:metabolism*; D004285:Dogs; D006801:Humans; D008253:Macaca mulatta; D008297:Male; D013058:Mass Spectrometry; D051379:Mice; D000077430:Nabumetone; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity
D000893:Anti-Inflammatory Agents; D002074:Butanones; D000077430:Nabumetone